​

2seventy bio (TSVT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

TSVT Stock Forecast

2seventy bio (TSVT) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $2.00, with a high of $2.00 and a low of $2.00. This represents a -19.68% decline from the last price of $2.49.

High: $2 Avg: $2 Low: $2 Last Closed Price: $2.49

TSVT Stock Rating

2seventy bio stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (71.43%), 1 Hold (14.29%), 1 Sell (14.29%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 1 5 Strong Sell Sell Hold Buy Strong Buy

TSVT Forecast vs Benchmarks

TypeNameUpside
Stock2seventy bio-19.68%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$2.00
Last Closing Price$2.49$2.49$2.49
Upside/Downside---19.68%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25-22-15
Dec, 24-22-15
Nov, 24223119
Oct, 24223119
Sep, 242241110
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 06, 2024Salveen RichterGoldman Sachs$2.00$4.56-56.14%-19.68%
May 02, 2022Goldman Sachs$26.00$13.4693.16%944.18%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Nov 12, 2024Goldman SachsSellSellhold
Jun 06, 2024Goldman SachsBuySelldowngrade
Apr 07, 2024CitigroupBuyBuyhold
Jan 31, 2024Leerink PartnersOutperformupgrade
Sep 13, 2023GuggenheimNeutraldowngrade
Mar 17, 2023WedbushOutperformOutperformhold
Jan 10, 2023SVB LeerinkOutperformOutperformhold
May 02, 2022Goldman SachsBuyinitialise
Apr 26, 2022Zacks Investment ResearchBuyupgrade

Financial Forecast

EPS Forecast

$-10 $-7 $-4 $-1 $2 $5 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-7.13$-4.42-----
Avg Forecast$-7.79$-4.36$-0.80$-0.47$-0.08$0.53$0.66
High Forecast$-9.72$-4.59$-0.81$-0.81$-0.32$0.36$0.44
Low Forecast$-5.64$-4.14$-0.79$-0.13$0.05$0.68$0.85
Surprise %-8.47%1.38%-----

Revenue Forecast

$35M $51M $67M $83M $99M $115M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$91.50M$100.39M-----
Avg Forecast$49.84M$105.36M$49.66M$68.06M$87.88M$80.97M$84.52M
High Forecast$39.25M$98.57M$44.51M$54.17M$85.94M$60.67M$63.33M
Low Forecast$59.33M$114.07M$53.09M$76.94M$89.82M$98.63M$102.96M
Surprise %83.56%-4.72%-----

Net Income Forecast

$-500M $-390M $-280M $-170M $-60M $50M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-254.14M$-217.57M-----
Avg Forecast$-383.79M$-217.57M$-39.47M$-27.87M$-6.58M$28.36M$32.52M
High Forecast$-478.73M$-226.15M$-39.89M$-39.72M$-15.55M$17.61M$21.92M
Low Forecast$-277.76M$-204.02M$-39.05M$-6.27M$2.39M$33.52M$41.75M
Surprise %-33.78%------

TSVT Forecast FAQ

Is 2seventy bio stock a buy?

2seventy bio stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 1 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that 2seventy bio is a favorable investment for most analysts.

What is 2seventy bio's price target?

2seventy bio's price target, set by 7 Wall Street analysts, averages $2 over the next 12 months. The price target range spans from $2 at the low end to $2 at the high end, suggesting a potential -19.68% change from the previous close price of $2.49.

How does 2seventy bio stock forecast compare to the average forecast of its sector, industry, and investment themes?

2seventy bio stock forecast shows a -19.68% downside, underperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for 2seventy bio over the past three months?

  • January 2025: 0% Strong Buy, 40.00% Buy, 40.00% Hold, 0% Sell, 20.00% Strong Sell.
  • December 2024: 0% Strong Buy, 40.00% Buy, 40.00% Hold, 0% Sell, 20.00% Strong Sell.
  • November 2024: 22.22% Strong Buy, 22.22% Buy, 33.33% Hold, 11.11% Sell, 11.11% Strong Sell.

What is 2seventy bio’s EPS forecast?

2seventy bio's average annual EPS forecast for its fiscal year ending in December is -0.8 for 2024, a -81.90% decrease from the reported $-4.42 in 2023. The prediction for 2025 is $-0.47, $-0.08 for 2026, $0.53 for 2027, and $0.66 for 2028.

What is 2seventy bio’s revenue forecast?

2seventy bio's average annual revenue forecast for its fiscal year ending in December is $49.66M for 2024, a -50.53% decrease from the reported $100.39M in 2023. The forecast for 2025 is $68.06M, $87.88M for 2026, $80.97M for 2027, and $84.52M for 2028.

What is 2seventy bio’s net income forecast?

For its fiscal year ending in December, 2seventy bio's average annual net income forecast is $-39.47M for 2024, reflecting a -81.86% decrease from the reported $-218M in 2023. The projection for 2025 is $-27.868M, $-6.581M for 2026, $28.36M for 2027, and $32.52M for 2028.